Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation [1]
Non-peer reviewed scientific publication
Anglais
SCIENSANO
Auteurs
Didier Breyer [3]; Philippe Herman [4]; Brandenburger,A. [5]; Gheysen,G. [6]; Remaut,E. [7]; Soumillion,P. [8]; J. Van Doorsselaere [9]; Custers,R. [10]; Katia Pauwels [11]; Myriam Sneyers [12]; Reheul,D. [13]Mots-clés
Résumé:
This paper discusses regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis and provides scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation of GMOs.